GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Shiller PE Ratio

Beijing Tiantan Biological Products (SHSE:600161) Shiller PE Ratio : 43.50 (As of May. 18, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Shiller PE Ratio?

As of today (2025-05-18), Beijing Tiantan Biological Products's current share price is ¥19.14. Beijing Tiantan Biological Products's E10 for the quarter that ended in Mar. 2025 was ¥0.44. Beijing Tiantan Biological Products's Shiller PE Ratio for today is 43.50.

The historical rank and industry rank for Beijing Tiantan Biological Products's Shiller PE Ratio or its related term are showing as below:

SHSE:600161' s Shiller PE Ratio Range Over the Past 10 Years
Min: 41.62   Med: 67.88   Max: 143.61
Current: 43.92

During the past years, Beijing Tiantan Biological Products's highest Shiller PE Ratio was 143.61. The lowest was 41.62. And the median was 67.88.

SHSE:600161's Shiller PE Ratio is ranked worse than
62.84% of 148 companies
in the Biotechnology industry
Industry Median: 33.74 vs SHSE:600161: 43.92

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Beijing Tiantan Biological Products's adjusted earnings per share data for the three months ended in Mar. 2025 was ¥0.120. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.44 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Beijing Tiantan Biological Products Shiller PE Ratio Historical Data

The historical data trend for Beijing Tiantan Biological Products's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Shiller PE Ratio Chart

Beijing Tiantan Biological Products Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 111.52 69.33 61.81 73.38 48.42

Beijing Tiantan Biological Products Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.05 65.19 64.08 48.42 46.54

Competitive Comparison of Beijing Tiantan Biological Products's Shiller PE Ratio

For the Biotechnology subindustry, Beijing Tiantan Biological Products's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Tiantan Biological Products's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Tiantan Biological Products's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Tiantan Biological Products's Shiller PE Ratio falls into.


;
;

Beijing Tiantan Biological Products Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Beijing Tiantan Biological Products's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=19.14/0.44
=43.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tiantan Biological Products's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Beijing Tiantan Biological Products's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.12/115.1156*115.1156
=0.120

Current CPI (Mar. 2025) = 115.1156.

Beijing Tiantan Biological Products Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 0.026 99.500 0.030
201509 -0.009 100.500 -0.010
201512 -0.017 100.600 -0.019
201603 0.000 102.200 0.000
201606 0.056 101.400 0.064
201609 0.045 102.400 0.051
201612 0.041 102.600 0.046
201703 0.030 103.200 0.033
201706 0.457 103.100 0.510
201709 0.068 104.100 0.075
201712 0.096 104.500 0.106
201803 0.063 105.300 0.069
201806 0.070 104.900 0.077
201809 0.087 106.600 0.094
201812 0.064 106.500 0.069
201903 0.075 107.700 0.080
201906 0.087 107.700 0.093
201909 0.097 109.800 0.102
201912 0.083 111.200 0.086
202003 0.076 112.300 0.078
202006 0.083 110.400 0.087
202009 0.118 111.700 0.122
202012 0.076 111.500 0.078
202103 0.083 112.662 0.085
202106 0.094 111.769 0.097
202109 0.139 112.215 0.143
202112 0.100 113.108 0.102
202203 0.067 114.335 0.067
202206 0.125 114.558 0.126
202209 0.108 115.339 0.108
202212 0.142 115.116 0.142
202303 0.133 115.116 0.133
202306 0.157 114.558 0.158
202309 0.160 115.339 0.160
202312 0.110 114.781 0.110
202403 0.160 115.227 0.160
202406 0.210 114.781 0.211
202409 0.160 115.785 0.159
202412 0.250 114.893 0.250
202503 0.120 115.116 0.120

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beijing Tiantan Biological Products  (SHSE:600161) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Beijing Tiantan Biological Products Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Tiantan Biological Products Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Boxing 2nd Road, Room 521, Building 8, Beijing Economic and Technological Development Zone, Beijing, CHN, 100024
Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business.
Executives
Zhang Yi senior management
Ci Xiang senior management
Fu Dao Xing Directors, senior managers
Hu Li Gang Director
Yang Hui Chuan Director
Liu Ya Na Directors, senior managers
He Yan Lin Directors, senior managers
Wang Jian Ming Supervisors
Wu Zhen Shan senior management

Beijing Tiantan Biological Products Headlines

No Headlines